InsiderTrades

Form 4 for APVO Aptevo Therapeutics Inc.

Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-02 · accession 0000950170-24-025915 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-03-05 2024-03-02+ APVO Lamothe Jeffrey G. EVP, COO M - OptEx — +9,167 33.8K +37% —
DM 2024-03-05 2024-03-02+ APVO Lamothe Jeffrey G. EVP, COO M - OptEx $0.00 -9,167 3,667 -71% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-03 M A 3,667 — 37,504 D — — (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
2 Common Common Stock 2024-03-02 M A 5,500 — 33,837 D — — (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
3 Derivative Restricted Stock Unit 2024-03-02 M D 5,500 $0.00 11,000 D — · — to — 5,500 Common Stock (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F2) On March 3, 2023, the reporting person was granted 16,500 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024.
4 Derivative Restricted Stock Unit 2024-03-03 M D 3,667 $0.00 3,667 D — · — to — 3,667 Common Stock (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F3) On June 7, 2022, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023.